Comparison of Glargine Insulin Versus Rosiglitazone Addition in Poorly Controlled Type 2 Diabetic Patients on Metformin Plus Sulfonylurea
Diabetes Care - United States
doi 10.2337/dc06-0564
Full Text
Open PDFAbstract
Available in full text
Date
October 25, 2006
Authors
Publisher
American Diabetes Association